Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Adalimumab formulations in Rheumatoid Arthritis
NCT01502423Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Jan 2012
- Primary completion
- Nov 2012
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of adalimumab in rheumatoid arthritis (RA), sponsored by AbbVie Inc.. Started Jan 2012; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01502423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01502423.